# Samsung Biologics wins $325M manufacturing contract from Celltrion

Samsung Biologics won a $324.8 million manufacturing contract from Celltrion Inc., marking their first major production deal.

- Type: Contract
- Announced: 2026-11-03
- Where: South Korea
- Value: $324.8M
- Status: announced
- Products: biopharmaceutical manufacturing services

## Companies

- [Samsung Biologics](https://endata.com/companies/15584.md) (supplier)
- [Celltrion](https://endata.com/companies/15585.md) (customer)

## Sources

- [kedglobal.com](https://www.kedglobal.com/us/bio-pharma/newsView/ked202611030007), 2026-11-04: "Samsung Biologics Co. has won $324.8 million manufacturing contract from Celltrion Inc."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.